The cancer cell's "power plants" as promising therapeutic targets: an overview
about
Inhibition of alanine aminotransferase in silico and in vivo promotes mitochondrial metabolism to impair malignant growthRedox-directed cancer therapeutics: molecular mechanisms and opportunitiesSodium MRI of glioma in animal models at ultrahigh magnetic fields.Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo.Dietary bioflavonoids inhibit Escherichia coli ATP synthase in a differential manner.Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cellsRole of Charged Residues in the Catalytic Sites of Escherichia coli ATP Synthase.Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity.Effect of structural modulation of polyphenolic compounds on the inhibition of Escherichia coli ATP synthaseThymoquinone Inhibits Escherichia coli ATP Synthase and Cell Growth.Insulin protects pancreatic acinar cells from cytosolic calcium overload and inhibition of plasma membrane calcium pump.Potential therapeutic target for malignant paragangliomas: ATP synthase on the surface of paraganglioma cells3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants.Phaeochromocytoma: a catecholamine and oxidative stress disorder.Asp residues of βDELSEED-motif are required for peptide binding in the Escherichia coli ATP synthaseEPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvateTargeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling.Clinical Response of Metastatic Breast Cancer to Multi-targeted Therapeutic Approach: A Single Case Report.Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.Human Hepatocellular Carcinoma Metabolism: Imaging by Hyperpolarized (13)C Magnetic Resonance Spectroscopy.Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvateMalate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism.Plasma membrane calcium pump regulation by metabolic stress.Metabolic alterations in cancer cells and therapeutic implications.The anti-cancer activities of jasmonates.Tumor glycolysis as a target for cancer therapy: progress and prospects.Mitochondrial ion channels as oncological targets.Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models.Comparative analysis of some aspects of mitochondrial metabolism in differentiated and undifferentiated neuroblastoma cells.Strategies to Target Glucose Metabolism in Tumor Microenvironment on Cancer by Flavonoids.Metabolic regulation of the PMCA: Role in cell death and survival.Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase.Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate.Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycinDownregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate.A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside.AMP-activated protein kinase couples 3-bromopyruvate-induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins.3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.Nutrichemistry, a means of preventing and healing chronic diseases.
P2860
Q24608319-79B0E422-7CBC-4266-84F5-47A72D39C601Q24645584-9BA8D109-511B-471F-AC29-87FE95EA4388Q30980381-05EF6443-47DD-4178-A054-DF12EB1A053DQ33570738-ED68E851-7D34-4AB5-82C6-B90085A6A6B8Q33823245-E6BB2E0A-2875-4A85-B484-9FE8E2479D69Q33880100-291A776D-50BD-48A3-89CF-FF9289FA6678Q34252667-2DF9BC71-992D-439A-AA6E-6E5A8EC471A9Q34892751-5F3C86DE-C897-401D-B780-4982F929D3E7Q35002406-3AB78F98-E533-4DDD-ACCB-D67F303A1474Q35634052-45BBD9B3-FEF3-455F-BAA2-693076954330Q35693971-C18A543B-F2CF-42A3-A3DB-034BC25F5196Q35758033-6C3C15F7-1BC9-40C1-852A-C238186C77DFQ35879138-B193A910-9E09-4BCF-8EE4-68D591677815Q36149357-2D12A13A-B524-4D14-B3CC-5FBB7C5FB71EQ36165353-E33F47E0-4139-42D4-9C32-A85DC4E6458CQ36342034-A5343466-6057-4DF4-8D0D-34C6F97F7E76Q36897348-CD2878F2-2942-4BE7-9DA9-753C6C0C28C5Q37129903-A9F1AEC0-9731-4762-8D61-4BC88A18208EQ37150883-87442FED-80E5-414F-B556-3CFC54F66FD5Q37287105-3E7F5D53-934B-40DA-8FF6-21B5370FA553Q37436821-399912A4-FB30-460E-9277-E04B503005D9Q37463153-528F82D7-BE4B-48ED-B7B1-3777758E212CQ37871358-59072E48-3719-420D-8DB4-EA3A13ADE533Q37908233-65CE11B7-B25F-40B8-A8DE-F68E711E35C5Q38063744-FFBE10F1-220C-4AD6-AFFF-01D2F2742DADQ38168262-01BE8D40-68C5-4EAD-B476-595C81502219Q38182357-9C62B4F5-D373-43D1-82E6-B9B9B6E4358FQ38187164-2A945916-F8B1-493A-97A4-6E1954A251BFQ39090765-DF2BF921-8FBB-4FCF-A49F-7258C73AB997Q39190194-D1897DD6-5FF9-47ED-8EB9-4577811E4262Q39380836-3627E4D9-05E2-4C12-B430-6058E4D8F8D8Q39398652-442A2D1B-EBE6-4872-BF12-FDE90C0D5294Q39402922-3E1FEC25-9D2F-459E-B09A-E65436043EB9Q39418495-0267493E-3449-43BB-A5A9-88E666EF4140Q39432374-D1F87AE7-8CB9-4C3B-8733-6228CF5FF130Q39473135-1CEFB6AB-D2D7-4184-8D8B-B936535F2FFCQ39653310-023FFA8E-4EB1-44A6-9A2D-A7EFA9D934BCQ40536323-56908A71-5CA0-40F7-858A-FCAC7C13286FQ41129737-BD5FF55C-597D-493B-9AB3-C3DB557CFE51Q42364225-17541532-61F8-457E-A16C-E2F6B609E342
P2860
The cancer cell's "power plants" as promising therapeutic targets: an overview
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The cancer cell's "power plants" as promising therapeutic targets: an overview
@ast
The cancer cell's "power plants" as promising therapeutic targets: an overview
@en
The cancer cell's "power plants" as promising therapeutic targets: an overview
@nl
type
label
The cancer cell's "power plants" as promising therapeutic targets: an overview
@ast
The cancer cell's "power plants" as promising therapeutic targets: an overview
@en
The cancer cell's "power plants" as promising therapeutic targets: an overview
@nl
prefLabel
The cancer cell's "power plants" as promising therapeutic targets: an overview
@ast
The cancer cell's "power plants" as promising therapeutic targets: an overview
@en
The cancer cell's "power plants" as promising therapeutic targets: an overview
@nl
P2860
P1476
The cancer cell's "power plants" as promising therapeutic targets: an overview
@en
P2093
Peter L Pedersen
P2860
P2888
P356
10.1007/S10863-007-9070-5
P407
P577
2007-02-01T00:00:00Z
P6179
1051187718